mendmedsBeta
Patient assistance
Free help paying for multiple sclerosis medications.
mendmeds tracks 7 multiple sclerosis medications, with 15 active assistance programs, each linked to its official source with the date we checked it.
Browse
Every multiple sclerosis medication we cover
- Kesimpta (ofatumumab)Medicare options3 active programsTypically around $7,400 per month without assistance
- Mavenclad (cladribine)2 active programs
- Mayzent (siponimod)Medicare options2 active programsTypically around $8,500 per month without assistance
- Ocrevus (ocrelizumab)2 active programs
- Tecfidera (dimethyl fumarate)Medicare options2 active programsTypically around $7,800 per month without assistance
- Tysabri (natalizumab)2 active programs
- Vumerity (diroximel fumarate)2 active programsTypically around $8,000 per month without assistance